Michael D Vives

US Patent:

20170224871, Aug 10, 2017

Filed:

Feb 6, 2017

Appl. No.:

15/425617

Inventors:

- Montclair NJ, US
Sheldon S Lin - Chatham NJ, US
Michael Vives - Mendham NJ, US

International Classification:

A61L 27/36
A61L 27/54

Abstract:

The present invention is a method for producing allograft tissue by applying an antimicrobial solution to allograft tissue. The antimicrobial solution exhibits antimicrobial activity to make allograft resistant to microbial organisms, such as bacterium.

US Patent:

20170035803, Feb 9, 2017

Filed:

Oct 19, 2016

Appl. No.:

15/297900

Inventors:

- New Brunswick NJ, US
John Koerner - Newark NJ, US
Michael J. Vives - Newark NJ, US
Joseph Benevenia - Montclair NJ, US
Eric Breitbart - South Orange NJ, US

International Classification:

A61K 33/24
A61F 2/44

Abstract:

Bone tissue materials comprising insulin-mimetic agents, such as suitable zinc, vanadium, tungsten, molybdenum, niobium, selenium, and manganese compounds, for facilitating spinal fusion of vertebrae M spinal fusion surgical procedures, and methods thereof. Additionally provided is a bone tissue kit for facilitating fusion of vertebrae in a spinal fusion surgical procedure including a composition formulated for facile application in a spinal fusion procedure comprising an insulin-mimetic agent and a pharmaceutically acceptable carrier. Yet further provided is an implantable device for enhancing spinal fusion including a prosthetic implant configured to stabilize and promote the fusion of two adjacent vertebrae, wherein the bone tissue contacting surfaces of the prosthetic implant are coated with a composition comprising an insulin-mimetic agent.

US Patent:

20150004249, Jan 1, 2015

Filed:

Sep 18, 2014

Appl. No.:

14/489642

Inventors:

- New Brunswick NJ, US
John Koerner - Newark NJ, US
Michael J. Vives - Newark NJ, US
Joseph Benevenia - Montclair NJ, US
Eric Breitbart - South Orange NJ, US

International Classification:

A61K 33/30
A61K 47/46
A61K 33/24

US Classification:

424641, 424646, 423555, 623 1716

Abstract:

Bone tissue materials comprising insulin-mimetic agents, such as suitable zinc, vanadium, tungsten, molybdenum, niobium, selenium, and manganese compounds, for facilitating spinal fusion of vertebrae in spinal fusion surgical procedures, and methods thereof. Additionally provided is a bone tissue kit for facilitating fusion of vertebrae in a spinal fusion surgical procedure including a composition formulated for facile application in a spinal fusion procedure comprising an insulin-mimetic agent and a pharmaceutically acceptable carrier. Yet further provided is an implantable device for enhancing spinal fusion including a prosthetic implant configured to stabilize and promote the fusion of two adjacent vertebrae, wherein the bone tissue contacting surfaces of the prosthetic implant are coated with a composition comprising an insulin-mimetic agent.